The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Surgistar sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Surgistar is a medical device company that develops and manufactures microsurgical cutting instruments for ophthalmic, ENT, surgical and dental applications. It offers safety knives and blades, cannulas, corneal products, trephines, handles and collets, oculoplastic products, refractive products and vitreoretinal products. It provides surgical products for orthopedic, dermatology, cardiovascular, hair transplant, neurosurgery, reconstructive, podiatry and gynecology. Surgistar also offers ophthalmic accessories including bimanual handpieces, coaxial handpieces, eye shields and eye spears, fluid filters, and others. The company operates its manufacturing facility in Vista, the US. Surgistar is headquartered in Vista, California, the US.
The key metrics of Surgistar related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Surgistar is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Surgistar.
For a detailed understanding of the performance of Surgistar, buy the report here.